Fortrea
Mark O'Reilly is a Senior Business Development Director at Fortrea, specializing in supporting European clients in bringing medical devices and diagnostics to market across Europe, the US, and the Rest of the World since June 2019. Prior to this role, Mark served as the Director of Business Development at Qmed Consulting, contributing to strategic consulting services for medical devices from concept to revenue. Mark's extensive experience in the medical field includes a tenure at NAMSA as Director of Business Development & Market Strategy EMEA, where responsibilities encompassed regulatory strategy, clinical evaluations, and market commercialization. Additional roles include Sales Director at Luto and Corporate Sales Manager at Kelly Services, focusing on pharmaceutical and medical device sectors. Mark holds a BSc(Hons) in Chemistry from the University of Leeds and a Diploma in Chemistry from Technological University of the Shannon, Athlone Campus.
This person is not in any teams
This person is not in any offices
Fortrea
13 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.